Chromium for Weight Loss

Verdict: Chromium does not produce meaningful weight loss

Chromium (usually chromium picolinate) does not cause meaningful weight loss. Trials detect a tiny statistical reduction of roughly half a kilogram to one kilogram, but it is far too small to matter, and regulators, clinics, and obesity specialists do not endorse chromium for shedding weight.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

The three pivotal pooled analyses reached the same verdict: any effect is statistically present but clinically negligible. Pittler 2003 (PMID 12664086, n=489) and Tian 2013 (PMID 24293292, n=392) each found about a 1.1 kg difference versus placebo, and Onakpoya 2013 (PMID 23495911, n=622) found only 0.50 kg (roughly 1.7 lb). All three judged the effect too small to be clinically meaningful and rated the underlying trials as low quality, with short follow-up and high risk of bias.

Individual trials do not change the picture. A small industry-funded pilot (Anton 2008, PMID 18715218, n=42) reported reduced food intake and cravings with a modest weight dip, but a larger placebo-controlled trial (Yazaki 2010, PMID 20105029, n=80) found no significant difference in weight, body composition, or insulin sensitivity over 24 weeks. No large, modern RCT has demonstrated a clinically relevant benefit.

Authorities align against weight-loss use. Europe's EFSA found no evidence of benefit and rejected chromium weight and appetite claims; the UK NHS says a balanced diet already supplies enough; the US FDA calls related claims highly uncertain. NIH ODS concedes only a very small change with little clinical significance, while Cleveland Clinic and Harvard Health do not recommend it. These converging findings produce the counter-evidence (Tier D) grade. Note that this concerns dietary trivalent chromium, distinct from carcinogenic hexavalent chromium.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.49
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
74%
Broadly consistent
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.21
L11 AI re-checkIndependent read
0.30
L1 ExamineGlobal benchmark
0.50
L2 PubMedPrimary literature
0.75
L3 MechanismPlausibility
0.75
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.49
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — | C→D 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Chromium picolinate for reducing body weight: meta-analysis of randomized trials
PMID: 12664086 2003 統合分析 n = 489
Finding: Pooled difference of -1.1 kg (95% CI -1.8 to -0.4) favoring chromium picolinate over placebo; authors flagged the effect size as small and of debatable clinical relevance, with poor methodological quality of included trials.
Academic Effect size: MD -1.1 kg (95% CI -1.8 to -0.4)
View on PubMed
Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials
PMID: 23495911 2013 統合分析 n = 622
Finding: Statistically significant but very small reduction in body weight (MD -0.50 kg, 95% CI -0.97 to -0.03) and body fat percentage (MD -0.68%, 95% CI -1.32 to -0.04); authors explicitly concluded the magnitude is too small to be clinically meaningful and overall evidence quality is low.
🟢 High quality Academic Effect size: MD -0.50 kg (95% CI -0.97 to -0.03); ~1.7 lb
View on PubMed
Chromium picolinate supplementation for overweight or obese adults (Cochrane-style systematic review / Tian et al.)
PMID: 24293292 2013 系統性回顧 n = 392
Finding: Chromium picolinate produced a statistically significant but small reduction in body weight (MD -1.1 kg, 95% CI -1.8 to -0.4) at 12-26 weeks; authors graded evidence as low quality and clinical relevance as uncertain. No significant difference in adverse events.
🟢 High quality Academic Effect size: MD -1.1 kg (95% CI -1.8 to -0.4)
View on PubMed
Effects of chromium picolinate on food intake and satiety
PMID: 18715218 2008 RCT (double-blind) n = 42
Finding: Chromium picolinate 1000 mcg/day reduced food intake, hunger and fat cravings, and produced a modest decrease in body weight vs placebo at 8 weeks; small pilot sample limits generalizability.
⚠️ Industry-funded Effect size: Small reduction in body weight; reductions in food intake (significant)
View on PubMed
A pilot study of chromium picolinate for weight loss
PMID: 20105029 2010 RCT (double-blind) n = 80
Finding: No statistically significant difference in body weight, body composition, or insulin sensitivity between chromium picolinate and placebo over 24 weeks; small underpowered pilot.
Academic Effect size: No significant between-group difference
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain. source↗
L4b EU EFSA
Against
The Panel concludes that there is no evidence of beneficial effects associated with chromium intake in healthy subjects ... no Average Requirement (AR) and Population Reference Intake (PRI) can be defined; chromium is not an essential nutrient. source↗
L4c UK NHS
Cautious
You should be able to get all the chromium you need by eating a varied and balanced diet. Around 25 micrograms of chromium a day should be enough for adults. Having 10mg or less a day of chromium from food and supplements is unlikely to cause any harm. source↗
L4d TW TFDA / 衛福部
Supportive
每日食用量中,其鉻之總含量不得高於200微克 source↗
L4e WHO
Not addressed
Chromium[VI] is carcinogenic to humans (Group 1). Metallic chromium and chromium[III] compounds are not classifiable as to their carcinogenicity to humans (Group 3). source↗
L5a NIH Office of Dietary Supplements
Cautious
Research suggests that chromium supplementation reduces body weight and body fat percentage to a very small, but statistically significant, extent. However, these effects have little clinical significance. source↗
L5b Mayo Clinic
Against
L5c Cleveland Clinic
Against
Chromium supplements are sold primarily as solutions for blood sugar regulation and weight loss... But there isn't good evidence to back up any of these health benefits. ... Newer studies have shown the effects of chromium on these and other conditions to be minimal at best. source↗
L5d Harvard Health
Cautious
However, chromium supplements have not been found to produce significant weight loss. source↗
L5e Specialty Society (condition-mapped)
Against
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-weight-loss-INT-chromium-001 繁體中文版 →